Clinical Trials List
Protocol NumberENX-200-CR-001
Completed
2022-01-15 - 2022-04-15
Phase I
Terminated1
-
Trial Applicant
PROTECH PHARMASERVICES CORPORATION
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2026/08/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
12 participants
-
Global
12 participants
